Alnylam Pharmaceuticals, Inc.

VICTORY CAPITAL MANAGEMENT INC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

220,866

Value ($000)

87,827

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	87,827	0.0%	220,866	12/31/2025
2025 Q3	11/12/2025	82,239	0.0%	180,349	9/30/2025
2025 Q2	8/13/2025	50,971	0.0%	156,294	6/30/2025
2025 Q1	5/2/2025	10,166	0.0%	37,649	3/31/2025
2024 Q4	2/6/2025	9,365	0.0%	39,797	12/31/2024
2024 Q3	11/5/2024	11,801	0.0%	42,909	9/30/2024
2024 Q2	8/5/2024	9,399	0.0%	38,680	6/30/2024
2024 Q1	5/3/2024	5,889	0.0%	39,404	3/31/2024
2023 Q4	2/5/2024	8,755	0.0%	45,738	12/31/2023
2023 Q3	11/6/2023	10,429	0.0%	58,887	9/30/2023
2023 Q2	7/27/2023	11,490	0.0%	60,493	6/30/2023
2023 Q1	5/2/2023	12,193	0.0%	60,870	3/31/2023
2022 Q4	4/25/2023	14,290	0.0%	60,132	12/31/2022
2022 Q3	11/2/2022	11,827	0.0%	59,087	9/30/2022
2022 Q2	8/1/2022	7,477	0.0%	51,265	6/30/2022
2022 Q1	5/4/2022	6,870	0.0%	51,485	3/31/2022
2021 Q4	2/7/2022	9,558	0.0%	56,362	12/31/2021
2021 Q3	11/2/2021	10,550	0.0%	55,878	9/30/2021
2021 Q2	8/3/2021	6,971	0.0%	41,122	6/30/2021
2021 Q1	5/4/2021	8,195	0.0%	58,044	3/31/2021
2020 Q4	2/1/2021	6,624	0.0%	50,964	12/31/2020
2020 Q3	11/9/2020	6,525	0.0%	44,813	9/30/2020
2020 Q2	8/7/2020	5,641	0.0%	38,087	6/30/2020
2020 Q1	5/4/2020	4,465	0.0%	41,017	3/31/2020
2019 Q4	2/6/2020	1,897	0.0%	16,473	12/31/2019